Nestmedic SA
WSE:NST
Nestmedic SA
Nestmedic SA is engaged in the production of medical devices and software. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2017-06-12. The firm focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
Nestmedic SA is engaged in the production of medical devices and software. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2017-06-12. The firm focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.
